Dysbiosis in Takayasu arteritis complicated with infectious endocarditis following tocilizumab administration

Scand J Rheumatol. 2023 Mar;52(2):224-226. doi: 10.1080/03009742.2022.2124620. Epub 2022 Oct 18.

Authors

T Shirai¹, H Sato¹, T Ishii¹, H Fujii¹

Affiliation

¹ Department of Rheumatology, Tohoku University Hospital, Sendai, Japan.

PMID: 36255303
DOI: 10.1080/03009742.2022.2124620

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Dysbiosis / complications
Endocarditis* / complications
Endocarditis* / diagnosis
Endocarditis* / drug therapy
Humans
Takayasu Arteritis* / complications
Takayasu Arteritis* / drug therapy

Substances

tocilizumab
Antibodies, Monoclonal, Humanized